Crossword Solver > found answer > TOSIT

Welcome to Anagrammer Crossword Genius! Keep reading below to see if tosit is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on tosit.

CROSSWORD
ANSWER

tosit

Searching in Crosswords ...

The answer TOSIT has 2 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word TOSIT is NOT valid in any word game. (Sorry, you cannot play TOSIT in Scrabble, Words With Friends etc)

Searching in Dictionaries ...

Definitions of tosit in various dictionaries:

TOSIT - Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced in mammalian cells. Combined with radioisotope i...

Word Research / Anagrams and more ...

Keep reading for additional results and analysis below.

Possible Crossword Clues
'I'll have ___ this one out'

Last Seen in these Crosswords & Puzzles
Jun 4 2015 Universal
Mar 12 2005 New York Times

Tosit might refer to
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced in mammalian cells. Combined with radioisotope iodine 131 it was called Iodine I 131 Tositumomab. Unlabelled tositumomab together with iodine-labelled tositumomab was called Bexxar and a personalized regimen using Bexxar was approved for the treatment of relapsed or chemotherapy/rituxan-refractory Non-Hodgkin lymphoma in 2003.The treatment regimen was personalized for each person receiving the drug in order to maximize the radiation delivered to the tumor and to minimize the amount of radiation to which the person would be exposed. A first dose of labelled antibody was given once, and whole-body radiation was measured with a gamma camera over seven days. Analysis of that imaging data allowed an optimal dose of labelled antibody to be calculated, which was then administered once a day, for up to seven days. Each time the labelled antibody was administered, it was always preceded by unlabelled antibody because early clinical trials had shown that total body residence times of radioactivity were longer in people who first received unlabelled antibody, so that a lower dose of labelled antibody was needed to deliver the required total dose of radiation; additionally labelled antibody targeted tumors better in people pre-treated with unlabelled antibody.This drug combination was developed by Corixa which was purchased by GlaxoSmithKline in 2005. It was sold for about $25,000 for one round of treatment.Sale of Bexxar was discontinued and marketing approval was withdrawn in February 2014 due to the decline in usage (fewer than 75 patients in 2012) even though it had a 70% response rate; the lack of demand was because oncologists could not sell it directly to patients but had to refer patients to third parties, and because of the emergence of other drugs that were as good and could be administered by the oncologists.

Tosit might refer to

Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced in mammalian cells. Combined with radioisotope iodine 131 it was called Iodine I 131 Tositumomab. Unlabelled tositumomab together with iodine-labelled tositumomab was called Bexxar and a personalized regimen using Bexxar was approved for the treatment of relapsed or chemotherapy/rituxan-refractory Non-Hodgkin lymphoma in 2003.The treatment regimen was personalized for each person receiving the drug in order to maximize the radiation delivered to the tumor and to minimize the amount of radiation to which the person would be exposed. A first dose of labelled antibody was given once, and whole-body radiation was measured with a gamma camera over seven days. Analysis of that imaging data allowed an optimal dose of labelled antibody to be calculated, which was then administered once a day, for up to seven days. Each time the labelled antibody was administered, it was always preceded by unlabelled antibody because early clinical trials had shown that total body residence times of radioactivity were longer in people who first received unlabelled antibody, so that a lower dose of labelled antibody was needed to deliver the required total dose of radiation; additionally labelled antibody targeted tumors better in people pre-treated with unlabelled antibody.This drug combination was developed by Corixa which was purchased by GlaxoSmithKline in 2005. It was sold for about $25,000 for one round of treatment.Sale of Bexxar was discontinued and marketing approval was withdrawn in February 2014 due to the decline in usage (fewer than 75 patients in 2012) even though it had a 70% response rate; the lack of demand was because oncologists could not sell it directly to patients but had to refer patients to third parties, and because of the emergence of other drugs that were as good and could be administered by the oncologists.

Anagrammer Crossword Solver is a powerful crossword puzzle resource site. We maintain millions of regularly updated crossword solutions, clues and answers of almost every popular crossword puzzle and word game out there. We encourage you to bookmark our puzzle solver as well as the other word solvers throughout our site. Explore deeper into our site and you will find many educational tools, flash cards and plenty more resources that will make you a much better player. This page shows you that 'I'll have ___ this one out' is a possible clue for tosit. You can also see that this clue and answer has appeared in these newspapers and magazines: June 4 2015 Universal, March 12 2005 New York Times . Tosit: Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced...